Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer

Background Advances in upper gastrointestinal endoscopic technology have enabled early detection and treatment of hypopharyngeal cancer. However, in-depth pharyngeal observations require sedation and are invasive. It is important to establish a minimally invasive and simple evaluation method to iden...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of cancer 2024-06, Vol.130 (10), p.1725-1731
Hauptverfasser: Hirai, Ryosuke, Kinugasa, Hideaki, Yamamoto, Shumpei, Ako, Soichiro, Tsutsumi, Koichiro, Abe, Makoto, Miyahara, Koji, Nakagawa, Masahiro, Otsuka, Motoyuki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1731
container_issue 10
container_start_page 1725
container_title British journal of cancer
container_volume 130
creator Hirai, Ryosuke
Kinugasa, Hideaki
Yamamoto, Shumpei
Ako, Soichiro
Tsutsumi, Koichiro
Abe, Makoto
Miyahara, Koji
Nakagawa, Masahiro
Otsuka, Motoyuki
description Background Advances in upper gastrointestinal endoscopic technology have enabled early detection and treatment of hypopharyngeal cancer. However, in-depth pharyngeal observations require sedation and are invasive. It is important to establish a minimally invasive and simple evaluation method to identify high-risk patients. Methods Eighty-seven patients with superficial hypopharyngeal cancer and 51 healthy controls were recruited. We assessed the methylation status of DCC , PTGDR1 , EDNRB , and ECAD , in tissue and saliva samples and verified the diagnostic accuracy by methylation analyses of their promoter regions using quantitative methylation-specific PCR. Results Significant differences between cancer and their surrounding non-cancerous tissues were observed in the methylation values of DCC ( p  = 0.003), EDNRB ( p  = 0.001), and ECAD ( p  = 0.043). Using receiver operating characteristic analyses of the methylation values in saliva samples, DCC showed the highest area under the curve values for the detection of superficial hypopharyngeal cancer (0.917, 95% confidence interval = 0.864–0.970), compared with those for EDNRB (0.680) and ECAD (0.639). When the cutoff for the methylation values of DCC was set at ≥0.163, the sensitivity to detect hypopharyngeal cancer was 82.8% and the specificity was 90.2%. Conclusions DCC methylation in saliva samples could be a non-invasive and efficient tool for early detection of hypopharyngeal cancer in high-risk patients.
doi_str_mv 10.1038/s41416-024-02654-2
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11091138</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3014004472</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-d7715c616f5387e81dfdb307fc5a43d0a4fa1a3c79861e16151dec7bad39b0f93</originalsourceid><addsrcrecordid>eNp9kU2P1DAMhiMEYoeFP8ABReLCpRA3adOeEBo-pUVc4BxlUmcmqzQpSTvS_AT-NenOsnwcOESW5ddPbL-EPAX2EhjvXmUBAtqK1aK8thFVfY9soOF1BV0t75MNY0xWrK_ZBXmU83VJe9bJh-SCdw3vZN1tyI_POB9OXs8uBqqD9qfsMo2Wvt1u6R4DUhdo1t4ddQnj5DHTItCBorXOOAwzHQsiDtTGREMMlQtHnd0R6YAzmhtw4eVlwrR2aE8PpylOB51OYY8lNToYTI_JA6t9xie38ZJ8e__u6_ZjdfXlw6ftm6vKiLqdq0FKaEwLrV1XwA4GO-w4k9Y0WvCBaWE1aG5k37WA0EIDAxq50wPvd8z2_JK8PnOnZTfiYMoGSXs1JTeWiVTUTv1dCe6g9vGoAFgPwLtCeHFLSPH7gnlWo8sGvdcB45IVZyAYE0LWRfr8H-l1XFI586pqBGecsxVYn1UmxZwT2rtpgKnVanW2WhWr1Y3VakU_-3OPu5Zf3hYBPwtyKZVLp99__wf7Ewvlt2c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3054303308</pqid></control><display><type>article</type><title>Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer</title><source>MEDLINE</source><source>Springer Online Journals Complete</source><creator>Hirai, Ryosuke ; Kinugasa, Hideaki ; Yamamoto, Shumpei ; Ako, Soichiro ; Tsutsumi, Koichiro ; Abe, Makoto ; Miyahara, Koji ; Nakagawa, Masahiro ; Otsuka, Motoyuki</creator><creatorcontrib>Hirai, Ryosuke ; Kinugasa, Hideaki ; Yamamoto, Shumpei ; Ako, Soichiro ; Tsutsumi, Koichiro ; Abe, Makoto ; Miyahara, Koji ; Nakagawa, Masahiro ; Otsuka, Motoyuki</creatorcontrib><description>Background Advances in upper gastrointestinal endoscopic technology have enabled early detection and treatment of hypopharyngeal cancer. However, in-depth pharyngeal observations require sedation and are invasive. It is important to establish a minimally invasive and simple evaluation method to identify high-risk patients. Methods Eighty-seven patients with superficial hypopharyngeal cancer and 51 healthy controls were recruited. We assessed the methylation status of DCC , PTGDR1 , EDNRB , and ECAD , in tissue and saliva samples and verified the diagnostic accuracy by methylation analyses of their promoter regions using quantitative methylation-specific PCR. Results Significant differences between cancer and their surrounding non-cancerous tissues were observed in the methylation values of DCC ( p  = 0.003), EDNRB ( p  = 0.001), and ECAD ( p  = 0.043). Using receiver operating characteristic analyses of the methylation values in saliva samples, DCC showed the highest area under the curve values for the detection of superficial hypopharyngeal cancer (0.917, 95% confidence interval = 0.864–0.970), compared with those for EDNRB (0.680) and ECAD (0.639). When the cutoff for the methylation values of DCC was set at ≥0.163, the sensitivity to detect hypopharyngeal cancer was 82.8% and the specificity was 90.2%. Conclusions DCC methylation in saliva samples could be a non-invasive and efficient tool for early detection of hypopharyngeal cancer in high-risk patients.</description><identifier>ISSN: 0007-0920</identifier><identifier>ISSN: 1532-1827</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/s41416-024-02654-2</identifier><identifier>PMID: 38538728</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/337/176/1988 ; 631/67/1536/1665/3016 ; 631/67/2322 ; Aged ; Biomarkers, Tumor - genetics ; Biomedical and Life Sciences ; Biomedicine ; Cancer ; Cancer Research ; Case-Control Studies ; DCC gene ; DCC Receptor - genetics ; DNA Methylation ; Drug Resistance ; Early Detection of Cancer - methods ; Epidemiology ; Female ; Genes, DCC - genetics ; Humans ; Hypopharyngeal Neoplasms - diagnosis ; Hypopharyngeal Neoplasms - genetics ; Invasiveness ; Male ; Middle Aged ; Molecular Medicine ; Oncology ; Pharynx ; Promoter Regions, Genetic ; Receptor, Endothelin B - genetics ; Risk groups ; ROC Curve ; Saliva ; Saliva - chemistry ; Throat cancer</subject><ispartof>British journal of cancer, 2024-06, Vol.130 (10), p.1725-1731</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c426t-d7715c616f5387e81dfdb307fc5a43d0a4fa1a3c79861e16151dec7bad39b0f93</cites><orcidid>0000-0003-4887-1609 ; 0000-0002-3602-9695</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41416-024-02654-2$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41416-024-02654-2$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38538728$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hirai, Ryosuke</creatorcontrib><creatorcontrib>Kinugasa, Hideaki</creatorcontrib><creatorcontrib>Yamamoto, Shumpei</creatorcontrib><creatorcontrib>Ako, Soichiro</creatorcontrib><creatorcontrib>Tsutsumi, Koichiro</creatorcontrib><creatorcontrib>Abe, Makoto</creatorcontrib><creatorcontrib>Miyahara, Koji</creatorcontrib><creatorcontrib>Nakagawa, Masahiro</creatorcontrib><creatorcontrib>Otsuka, Motoyuki</creatorcontrib><title>Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Background Advances in upper gastrointestinal endoscopic technology have enabled early detection and treatment of hypopharyngeal cancer. However, in-depth pharyngeal observations require sedation and are invasive. It is important to establish a minimally invasive and simple evaluation method to identify high-risk patients. Methods Eighty-seven patients with superficial hypopharyngeal cancer and 51 healthy controls were recruited. We assessed the methylation status of DCC , PTGDR1 , EDNRB , and ECAD , in tissue and saliva samples and verified the diagnostic accuracy by methylation analyses of their promoter regions using quantitative methylation-specific PCR. Results Significant differences between cancer and their surrounding non-cancerous tissues were observed in the methylation values of DCC ( p  = 0.003), EDNRB ( p  = 0.001), and ECAD ( p  = 0.043). Using receiver operating characteristic analyses of the methylation values in saliva samples, DCC showed the highest area under the curve values for the detection of superficial hypopharyngeal cancer (0.917, 95% confidence interval = 0.864–0.970), compared with those for EDNRB (0.680) and ECAD (0.639). When the cutoff for the methylation values of DCC was set at ≥0.163, the sensitivity to detect hypopharyngeal cancer was 82.8% and the specificity was 90.2%. Conclusions DCC methylation in saliva samples could be a non-invasive and efficient tool for early detection of hypopharyngeal cancer in high-risk patients.</description><subject>631/337/176/1988</subject><subject>631/67/1536/1665/3016</subject><subject>631/67/2322</subject><subject>Aged</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Case-Control Studies</subject><subject>DCC gene</subject><subject>DCC Receptor - genetics</subject><subject>DNA Methylation</subject><subject>Drug Resistance</subject><subject>Early Detection of Cancer - methods</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Genes, DCC - genetics</subject><subject>Humans</subject><subject>Hypopharyngeal Neoplasms - diagnosis</subject><subject>Hypopharyngeal Neoplasms - genetics</subject><subject>Invasiveness</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Pharynx</subject><subject>Promoter Regions, Genetic</subject><subject>Receptor, Endothelin B - genetics</subject><subject>Risk groups</subject><subject>ROC Curve</subject><subject>Saliva</subject><subject>Saliva - chemistry</subject><subject>Throat cancer</subject><issn>0007-0920</issn><issn>1532-1827</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kU2P1DAMhiMEYoeFP8ABReLCpRA3adOeEBo-pUVc4BxlUmcmqzQpSTvS_AT-NenOsnwcOESW5ddPbL-EPAX2EhjvXmUBAtqK1aK8thFVfY9soOF1BV0t75MNY0xWrK_ZBXmU83VJe9bJh-SCdw3vZN1tyI_POB9OXs8uBqqD9qfsMo2Wvt1u6R4DUhdo1t4ddQnj5DHTItCBorXOOAwzHQsiDtTGREMMlQtHnd0R6YAzmhtw4eVlwrR2aE8PpylOB51OYY8lNToYTI_JA6t9xie38ZJ8e__u6_ZjdfXlw6ftm6vKiLqdq0FKaEwLrV1XwA4GO-w4k9Y0WvCBaWE1aG5k37WA0EIDAxq50wPvd8z2_JK8PnOnZTfiYMoGSXs1JTeWiVTUTv1dCe6g9vGoAFgPwLtCeHFLSPH7gnlWo8sGvdcB45IVZyAYE0LWRfr8H-l1XFI586pqBGecsxVYn1UmxZwT2rtpgKnVanW2WhWr1Y3VakU_-3OPu5Zf3hYBPwtyKZVLp99__wf7Ewvlt2c</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Hirai, Ryosuke</creator><creator>Kinugasa, Hideaki</creator><creator>Yamamoto, Shumpei</creator><creator>Ako, Soichiro</creator><creator>Tsutsumi, Koichiro</creator><creator>Abe, Makoto</creator><creator>Miyahara, Koji</creator><creator>Nakagawa, Masahiro</creator><creator>Otsuka, Motoyuki</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4887-1609</orcidid><orcidid>https://orcid.org/0000-0002-3602-9695</orcidid></search><sort><creationdate>20240601</creationdate><title>Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer</title><author>Hirai, Ryosuke ; Kinugasa, Hideaki ; Yamamoto, Shumpei ; Ako, Soichiro ; Tsutsumi, Koichiro ; Abe, Makoto ; Miyahara, Koji ; Nakagawa, Masahiro ; Otsuka, Motoyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-d7715c616f5387e81dfdb307fc5a43d0a4fa1a3c79861e16151dec7bad39b0f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>631/337/176/1988</topic><topic>631/67/1536/1665/3016</topic><topic>631/67/2322</topic><topic>Aged</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Case-Control Studies</topic><topic>DCC gene</topic><topic>DCC Receptor - genetics</topic><topic>DNA Methylation</topic><topic>Drug Resistance</topic><topic>Early Detection of Cancer - methods</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Genes, DCC - genetics</topic><topic>Humans</topic><topic>Hypopharyngeal Neoplasms - diagnosis</topic><topic>Hypopharyngeal Neoplasms - genetics</topic><topic>Invasiveness</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Pharynx</topic><topic>Promoter Regions, Genetic</topic><topic>Receptor, Endothelin B - genetics</topic><topic>Risk groups</topic><topic>ROC Curve</topic><topic>Saliva</topic><topic>Saliva - chemistry</topic><topic>Throat cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hirai, Ryosuke</creatorcontrib><creatorcontrib>Kinugasa, Hideaki</creatorcontrib><creatorcontrib>Yamamoto, Shumpei</creatorcontrib><creatorcontrib>Ako, Soichiro</creatorcontrib><creatorcontrib>Tsutsumi, Koichiro</creatorcontrib><creatorcontrib>Abe, Makoto</creatorcontrib><creatorcontrib>Miyahara, Koji</creatorcontrib><creatorcontrib>Nakagawa, Masahiro</creatorcontrib><creatorcontrib>Otsuka, Motoyuki</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hirai, Ryosuke</au><au>Kinugasa, Hideaki</au><au>Yamamoto, Shumpei</au><au>Ako, Soichiro</au><au>Tsutsumi, Koichiro</au><au>Abe, Makoto</au><au>Miyahara, Koji</au><au>Nakagawa, Masahiro</au><au>Otsuka, Motoyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>130</volume><issue>10</issue><spage>1725</spage><epage>1731</epage><pages>1725-1731</pages><issn>0007-0920</issn><issn>1532-1827</issn><eissn>1532-1827</eissn><abstract>Background Advances in upper gastrointestinal endoscopic technology have enabled early detection and treatment of hypopharyngeal cancer. However, in-depth pharyngeal observations require sedation and are invasive. It is important to establish a minimally invasive and simple evaluation method to identify high-risk patients. Methods Eighty-seven patients with superficial hypopharyngeal cancer and 51 healthy controls were recruited. We assessed the methylation status of DCC , PTGDR1 , EDNRB , and ECAD , in tissue and saliva samples and verified the diagnostic accuracy by methylation analyses of their promoter regions using quantitative methylation-specific PCR. Results Significant differences between cancer and their surrounding non-cancerous tissues were observed in the methylation values of DCC ( p  = 0.003), EDNRB ( p  = 0.001), and ECAD ( p  = 0.043). Using receiver operating characteristic analyses of the methylation values in saliva samples, DCC showed the highest area under the curve values for the detection of superficial hypopharyngeal cancer (0.917, 95% confidence interval = 0.864–0.970), compared with those for EDNRB (0.680) and ECAD (0.639). When the cutoff for the methylation values of DCC was set at ≥0.163, the sensitivity to detect hypopharyngeal cancer was 82.8% and the specificity was 90.2%. Conclusions DCC methylation in saliva samples could be a non-invasive and efficient tool for early detection of hypopharyngeal cancer in high-risk patients.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>38538728</pmid><doi>10.1038/s41416-024-02654-2</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-4887-1609</orcidid><orcidid>https://orcid.org/0000-0002-3602-9695</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 2024-06, Vol.130 (10), p.1725-1731
issn 0007-0920
1532-1827
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11091138
source MEDLINE; Springer Online Journals Complete
subjects 631/337/176/1988
631/67/1536/1665/3016
631/67/2322
Aged
Biomarkers, Tumor - genetics
Biomedical and Life Sciences
Biomedicine
Cancer
Cancer Research
Case-Control Studies
DCC gene
DCC Receptor - genetics
DNA Methylation
Drug Resistance
Early Detection of Cancer - methods
Epidemiology
Female
Genes, DCC - genetics
Humans
Hypopharyngeal Neoplasms - diagnosis
Hypopharyngeal Neoplasms - genetics
Invasiveness
Male
Middle Aged
Molecular Medicine
Oncology
Pharynx
Promoter Regions, Genetic
Receptor, Endothelin B - genetics
Risk groups
ROC Curve
Saliva
Saliva - chemistry
Throat cancer
title Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A35%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methylation%20analysis%20of%20DCC%20gene%20in%20saliva%20samples%20is%20an%20efficient%20method%20for%20non-invasive%20detection%20of%20superficial%20hypopharyngeal%20cancer&rft.jtitle=British%20journal%20of%20cancer&rft.au=Hirai,%20Ryosuke&rft.date=2024-06-01&rft.volume=130&rft.issue=10&rft.spage=1725&rft.epage=1731&rft.pages=1725-1731&rft.issn=0007-0920&rft.eissn=1532-1827&rft_id=info:doi/10.1038/s41416-024-02654-2&rft_dat=%3Cproquest_pubme%3E3014004472%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3054303308&rft_id=info:pmid/38538728&rfr_iscdi=true